We are live on ! Find out more
GAA

Green Alpha Advisors Portfolio holdings

AUM $148M Turnover 14.17%
1-Year Est. Return 98.22%
This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+98.22%
3 Year Est. Return
+315.88%
5 Year Est. Return
+340.2%
10 Year Est. Return
–
AUM
$124M
AUM Growth
-$13.6M
Cap. Flow
-$14.3M
Cap. Flow %
-11.47%
Top 10 Hldgs %
24%
Holding
143
New
1
Increased
2
Reduced
135
Closed
5
Avg Time Held
2.5 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
1.3 years

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$559K
2
LRCX icon
Lam Research
LRCX
+$555K
3
IBM icon
IBM
IBM
+$429K
4
CRSP icon
CRISPR Therapeutics
CRSP
+$423K
5
QCOM icon
Qualcomm
QCOM
+$422K

Sector Composition

Rank Sector Weight
1 Technology 48.01%
2 Real Estate 16.13%
3 Healthcare 6.95%
4 Consumer Staples 6.8%
5 Industrials 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
QSI icon
126
Quantum-Si Incorporated
QSI
$250M
$136K 0.11%
129,259
-5,357
-4% -$8.59K
2023 Q3
3 quarters
PRME icon
127
Prime Medicine
PRME
$628M
$135K 0.11%
26,245
-7,493
-22% -$45.4K
2023 Q2
4 quarters
BFLY icon
128
Butterfly Network
BFLY
$1.97B
$135K 0.11%
160,200
-6,844
-4% -$6.39K
2023 Q3
3 quarters
PSNL icon
129
Personalis
PSNL
$1.68B
$127K 0.1%
108,591
-10,362
-9% -$14.2K
2021 Q2
12 quarters
CRBU icon
130
Caribou Biosciences
CRBU
$48.9M
$127K 0.1%
77,371
-6,150
-7% -$19.7K
2021 Q3
11 quarters
GGR icon
131
Gogoro
GGR
$64.2M
$111K 0.09%
3,609
-199
-5% -$6.14K
2023 Q1
5 quarters
VERV icon
132
DELISTED
Verve Therapeutics
VERV
$94.8K 0.08%
19,433
-5,507
-22% -$34.6K
2023 Q3
3 quarters
NRGV icon
133
Energy Vault
NRGV
$542M
$92.5K 0.07%
97,446
-4,461
-4% -$5.54K
2022 Q2
8 quarters
DNA icon
134
Ginkgo Bioworks
DNA
$694M
$74.4K 0.06%
5,567
-1,874
-25% -$55.9K
2023 Q1
5 quarters
ABCL icon
135
AbCellera Biologics
ABCL
$3.86B
$73.1K 0.06%
24,709
-3,638
-13% -$13.8K
2021 Q3
11 quarters
CVAC icon
136
DELISTED
CureVac
CVAC
$65.8K 0.05%
19,340
-2,778
-13% -$9.09K
2022 Q2
8 quarters
PACB icon
137
Pacific Biosciences
PACB
$544M
$46.7K 0.04%
34,096
-15,851
-32% -$32K
2021 Q2
12 quarters
MAXN icon
138
DELISTED
Maxeon Solar Technologies
MAXN
$38.2K 0.03%
447
-14
-3% -$2.96K
2020 Q4
14 quarters
ARCT icon
139
Arcturus Therapeutics
ARCT
$298M
– –
-8,414
Closed -$284K –
EXAS icon
140
DELISTED
Exact Sciences
EXAS
– –
-4,469
Closed -$309K –
NTLA icon
141
Intellia Therapeutics
NTLA
$1.54B
– –
-7,964
Closed -$219K –
TXG icon
142
10x Genomics
TXG
$9.09B
– –
-5,713
Closed -$214K –
NVTA
143
DELISTED
Invitae Corporation
NVTA
– –
-450,148
Closed -$4.95K –

Similar funds

Green Alpha Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Green Alpha Advisors held 143 positions worth $124M, down 9.9% from $138M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Green Alpha Advisors withdrew a net $14.3M in Q2 2024, closing 5 positions and reducing 135 holdings. Its most notable exit was Exact Sciences, an estimated $309K position sold in full.

By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 46% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Green Alpha Advisors opened a new position in Guardant Health worth $205K.

  • Green Alpha Advisors's largest Q2 2024 buy was Guardant Health: 7,108 shares worth $205K.
  • Green Alpha Advisors added most to Nextpower Inc. Common Stock in Q2 2024, an estimated $101K increase.
  • Green Alpha Advisors's biggest Q2 2024 reduction was TSMC, cutting an estimated $559K.
  • Green Alpha Advisors fully exited Exact Sciences in Q2 2024, selling an estimated $309K.
  • Green Alpha Advisors's ten largest holdings make up 24% of its $124M portfolio in Q2 2024.
  • Green Alpha Advisors opened 1 new position and closed 5 in Q2 2024.
  • Green Alpha Advisors's portfolio value fell 9.9% quarter-over-quarter to $124M.

Based on Green Alpha Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.